Publications by authors named "R D Humphrey"

Current intensified chemotherapy regimens have significantly increased survival rates for pediatric patients with T-cell acute lymphoblastic leukemia (T-ALL), but these treatments can result in serious adverse effects; furthermore, patients who are resistant to chemotherapy or who relapse have inferior outcomes, together highlighting the need for improved therapeutic strategies. Despite recent advances in stratifying T-ALL into molecular subtypes with distinct driver mutations, efforts to target the tumor-intrinsic genomic alterations critical for T-ALL progression have yet to translate into more effective and less toxic therapies. Ample evidence now indicates that extrinsic factors in the leukemic microenvironment are critical for T-ALL growth, infiltration, and therapeutic resistance.

View Article and Find Full Text PDF
Article Synopsis
  • ASCEND PLUS is a large clinical trial in the UK aimed at preventing cardiovascular events in individuals with type 2 diabetes by using oral semaglutide, emphasizing a decentralized recruitment and follow-up method.
  • The trial significantly involved patient and public input (PPIE) throughout its design and implementation, utilizing focus groups and an advisory group to ensure diverse perspectives were included.
  • Results from the PPIE activities influenced key trial features, such as providing participants with flexible options for the screening process and creating user-friendly information materials, which were refined based on feedback from the advisory group.
View Article and Find Full Text PDF

T cells are often absent from human cancer tissues during both spontaneously induced immunity and therapeutic immunotherapy, even in the presence of a functional T cell-recruiting chemokine system, suggesting the existence of T cell exclusion mechanisms that impair infiltration. Using a genome-wide in vitro screening platform, we identified a role for phospholipase A2 group 10 (PLA2G10) protein in T cell exclusion. PLA2G10 up-regulation is widespread in human cancers and is associated with poor T cell infiltration in tumor tissues.

View Article and Find Full Text PDF

Introduction: Menthol tobacco products have been marketed disproportionately to communities of color for decades.

Methods: In Los Angeles County, California, a health marketing campaign, which used glossy visuals and attractive people in appealing poses, reminiscent of tobacco marketing tactics, was created and implemented to educate smokers on the health risks of using menthol cigarettes. The campaign encouraged smokers to make a quit attempt by offering access to free or low-cost resources through the Kick It California quitline and the LAQuits website (laquits.

View Article and Find Full Text PDF

We previously found that T-cell acute lymphoblastic leukemia (T-ALL) requires support from tumor-associated myeloid cells, which activate Insulin Like Growth Factor 1 Receptor (IGF1R) signaling in leukemic blasts. However, IGF1 is not sufficient to sustain T-ALL in vitro, implicating additional myeloid-mediated signals in leukemia progression. Here, we find that T-ALL cells require close contact with myeloid cells to survive.

View Article and Find Full Text PDF